57 episodes

Welcome to the Precision Medicine Podcast by Trapelo. This is the podcast where experts come to discuss the problems oncologists, reference labs, and payers face as precision medicine grows, and consider solutions for advancing the quality of patient-centered cancer care.

Precision Medicine Podcast Trapelo

    • Health & Fitness
    • 4.8 • 30 Ratings

Welcome to the Precision Medicine Podcast by Trapelo. This is the podcast where experts come to discuss the problems oncologists, reference labs, and payers face as precision medicine grows, and consider solutions for advancing the quality of patient-centered cancer care.

    Do We Have the Will to Address Inequality in Precision Oncology? A Conversation with Dr. Karen Winkfield

    Do We Have the Will to Address Inequality in Precision Oncology? A Conversation with Dr. Karen Winkfield

    In this episode, we are joined by Dr. Karen Winkfield, Executive Director of the Meharry-Vanderbilt Alliance, appointee to President Joe Biden's National Cancer Advisory Board, and co-host of the weekly podcast, 3 Black Docs (https://www.3blackdocs.com/), which is dedicated to educating the community about health and health disparities in an approachable and entertaining way.Dr. Winkfield’s commitment to her calling was clear by the fact that she joins us during her vacation to discuss racial disparities in the healthcare system that prevent many Black patients from seeking and receiving appropriate care. She tells us that she didn’t discover her calling early and, due to family and cultural barriers of her own, she almost didn’t pursue it at all. In fact, it took the support of a dedicated high-school teacher and nine emotional years to finish her undergraduate degree in biochemistry to get her where she is today as a practicing radiation oncologist.Off the top we ask Dr. Winkfield what can be learned from greater participation of underrepresented groups in clinical trials or greater participation in the healthcare system. She notes that Black people are still dying of cancer at a much higher rate than the rest of the population, and while there are some biologic reasons, much of the cause is under-representation in cancer clinical trials. We point out her step-by-step plan to address this type of imbalance in the healthcare system, and we are reminded that this is nothing new as she has been working to help address it for decades. She says, "Okay, I laid out a plan, but there's been a plan out for ending cancer disparities for over 20 years." The unequal burden document that was essentially kind of written by the Institutes of Medicine. Congress actually was the one who said, "Hey, we need to kind of understand what's going on with this cancer disparities thing." The whole plan is outlined.​Part of what the challenge is now is, do we have the will, do we have the will to do what is needed? Yes, I mean, there are those of us who've been kind of yelling from the mountaintops for decades now that we need to do something different because people are dying.” She goes on to explain that balancing disparity isn’t as easy as, say, offering translation services, because institutionalized racism runs so deep that it presents barriers at every step. For instance, she says that if you look at the Cancer Genome Atlas Program, which has over 11,000 primary cancer samples, only 25 of those specimens are from prostate cancers derived from Black men, despite the fact that Black men not only have a much greater risk of developing prostate cancer, probably twice as high as any other racial ethnic group, and they're two-and-a-half times as likely to die of prostate cancer. She says, in America, your wealth directly impacts your health. Your zip code impacts your outcome more than your genetic code. We naturally asked what role technology can play in eliminating healthcare disparities, and she says that without more representative patient samples, trials and access, precision medicine can never be precise.In fact, she believes precision medicine can actually deepen the divide if it is not used with precision in terms of the whole person.Where do they come from? What are barriers to them accessing precision medicine, such as transportation or even paying for parking? Dr. Winkfield is a strong proponent of navigators who help cancer patients overcome those institutional barriers to ensure that they have equal access to the promise of precision medicine. She says, “These are the things, the social determinants of health,

    • 52 min
    Dr. Stephen Kingsmore on Scaling Whole Genome Sequencing for Uncovering Genetic Defects in Infants

    Dr. Stephen Kingsmore on Scaling Whole Genome Sequencing for Uncovering Genetic Defects in Infants

    In episode 55 of the Precision Medicine Podcast, (https://www.trapelohealth.com/precision-medicine-for-children) we welcome Dr. Stephen Kingsmore, President and CEO of the Rady Children's Institute for Genomic Medicine. Dr. Kingsmore joins us to discuss the extraordinary role whole genome sequencing is playing in prolonging and improving the life of critically ill newborns.Read the full summary and tune in here (https://www.trapelohealth.com/precision-medicine-for-children)!

    • 38 min
    Leading Thoracic Oncologist, Dr. Christian Rolfo, Explains How Liquid Biopsies Are Advancing Precision Medicine

    Leading Thoracic Oncologist, Dr. Christian Rolfo, Explains How Liquid Biopsies Are Advancing Precision Medicine

    Dr. Christian Rolfo, President of the International Society of Liquid Biopsy and Associate Director for Clinical Research at the Center of Thoracic Oncology at the Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai in New York City, joins us to explain the unique role liquid biopsies are playing in the diagnosis and treatment of cancer.Read the full summary, subscribe and tune in here (https://www.trapelohealth.com/precision-medicine-podcast-liquid-biopsy).Learn more about our lead sponsor Trapelo Health here. (https://www.trapelohealth.com/)

    • 30 min
    LUNGevity Leaders Discuss Their Commitment to Educating Lung Cancer Patients About the Importance of Biomarker Testing

    LUNGevity Leaders Discuss Their Commitment to Educating Lung Cancer Patients About the Importance of Biomarker Testing

    In this Precision Medicine Podcast (https://www.trapelohealth.com/lungevity) episode, we are joined by Dr. Belinda King-Kallimanis, Director of Patient-Focused Research at LUNGevity—an organization that brings together research, education and support services for patients and caregivers in the lung cancer community—and Nichelle Stigger, LUNGevity board member and lung cancer survivor. They sat down with us to discuss everything from the importance of patient-friendly language in lung cancer to discrepancies in access to biomarker testing and what LUNGevity is doing to improve the status quo. Read the full summary and listen here (https://www.trapelohealth.com/lungevity).

    • 40 min
    Then and Now: The Progress of Precision Medicine Diagnostics with Hannah Mamuszka and Lena Chaihorsky of Alva10

    Then and Now: The Progress of Precision Medicine Diagnostics with Hannah Mamuszka and Lena Chaihorsky of Alva10

    In celebration of the three-year anniversary of the Precision Medicine Podcast, we take a look back at how far precision diagnostics have come with the help of one of our first guests Hannah Mamuszka, Founder and CEO of Alva10, and her colleague Lena Chaihorsky. Both women are focused on resolving the knowledge gap between payers and diagnostic companies and moving diagnostics to the forefront of the precision medicine conversation.Read the full summary and tune in here! (https://www.trapelohealth.com/precision-medicine-diagnostics)

    • 34 min
    Author and Breast Cancer “Previvor” Ali Rogan on How Progress in Precision Medicine Empowers Patients to Make Informed Decisions

    Author and Breast Cancer “Previvor” Ali Rogan on How Progress in Precision Medicine Empowers Patients to Make Informed Decisions

    In this episode, in honor of Breast Cancer Awareness Month (https://www.nationalbreastcancer.org/breast-cancer-awareness-month), we speak with Ali Rogin, author of Beat Breast Cancer Like a Boss and award-winning producer of PBS NewsHour. Ali is what is commonly known as a breast cancer previvor, someone who knows they have a mutation that may lead to cancer and takes preventative steps to avoid a diagnosis. With the growth of genetic testing and precision medicine and the ability to isolate genes that can lead to cancer, more and more people may fall into the category of previvors. For instance, women that have the BRCA 1 or 2 mutation, as Rogin does, have a 70% chance of developing breast cancer by the age of 80. Rogin says progress in precision medicine has given these women options they would never have had before, enabling them to make proactive, informed decisions about their future health.

    • 40 min

Customer Reviews

4.8 out of 5
30 Ratings

30 Ratings

Zebray ,

Awesome

Excellent source of information spanning a wide range of stake holders across the spectrum of precision medicine.

Bclan13 ,

Pretty good but “unempathetic ‘yeahs’”

Generally pretty good content but have listened to multiple podcasts where moderator responds to really deep life and death statements from guests (eg ROS1ders talking about the ends of their lives, women leadership expert talking about under representation) with “yeah...<next question>.” I just want moderator to know that that’s happening and consider finding a more respectful and empathetic way to keep things moving. But keep up the podcast it’s good and needed - maybe could be a bit deeper as audience is expert not intro.

Bobby Zomby ,

Extremely thoughtful

Well done podcast covering some big issues in this space. Look forward to hearing more

You Might Also Like